Benitec Biopharma Inc. (BNTC)
BNTC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2024-06-30, https://www.sec.gov/Archives/edgar/data/1808898/000119312524226968/0001193125-24-226968-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2026-06-30.
Profile
| Field | Value |
|---|---|
| Ticker | BNTC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001808898 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$21.8M |
| Operating income | -$22.5M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $78.3M |
| Total assets | $79.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-09-14 |
| Latest annual report | 10-K | 2026-09-14 |
| Latest quarterly / interim | 10-Q | 2026-05-14 |
| Latest current report | 8-K | 2026-10-05 |
| Latest proxy | DEFA14A | 2025-11-12 |
Source: SEC EDGAR submissions feed, 331 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -6.8% |
| 1 month | -24.2% |
| 3 months | -33.8% |
| Year to date | -37.8% |
| 1 year | -44.1% |
| From 52-week high | -49.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CYPH | Cypherpunk Technologies Inc. | $2.84 | -2.07% | $306.1M |
| TTRX | Turn Therapeutics Inc. | $10.60 | -4.59% | $315.8M |
| CTNM | Contineum Therapeutics Inc. | $8.42 | -1.69% | $316.8M |
| INDP | Indaptus Therapeutics Inc. | $2.39 | -2.05% | $318.4M |
| PRLD | Prelude Therapeutics Incorporated | $3.56 | -4.81% | $284.1M |
| FULC | Fulcrum Therapeutics Inc. | $3.68 | -1.87% | $281.1M |
| ENTA | Enanta Pharmaceuticals Inc. | $11.52 | -6.34% | $335.5M |
| ARCT | Arcturus Therapeutics Holdings Inc. | $12.03 | -4.60% | $341.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier